Walter Nyamukondiwa recently in Msampakaruma
FOR women in the remote communities of Msampakaruma in Nyaminyami, Kariba district, the fight against cervical cancer no longer begins with the costly journey to a distant hospital.
Screening, diagnosis and treatment are now available at their doorstep, bringing relief to hundreds of women and girls who previously faced geographical, financial and other barriers to accessing essential healthcare.
The development marks an important step in Zimbabwe’s efforts to eliminate cervical cancer as a public health threat, particularly in rural communities, where distance and limited access to specialised services can delay diagnosis and treatment.
Previously, women requiring further assessment and treatment had to travel to Siakobvu, Karoi or Kariba, incurring transport costs and other expenses that often discouraged them from seeking timely medical attention.
For Ms Tsitsi Mudzingwa of Gunguhwe village, having the services at Msampakaruma Clinic is a welcome development that could make the difference between early intervention and a potentially life-threatening diagnosis.
“We are thankful to the Government and its partners, the Clinton Health Access Initiative (CHAI), the Judith Neilson Foundation (JNF) and Unitaid, for bringing health services closer to our communities,” she said.
“You would need to travel to Siakobvu, Karoi or Kariba for further care, which was costly.”
Bringing healthcare closer to rural women
Village health worker Mrs Patience Siachazangwa said community awareness campaigns could only achieve meaningful results if women had access to screening and treatment after being encouraged to seek medical attention.
“We have worked hard as village health workers to bring awareness to the community, but our efforts would fail because there were no suitable services once women got to a health centre,” she said.
She encouraged women and girls to take advantage of the services, emphasising that early detection was critical in preventing deaths from cervical cancer.
Msampakaruma Clinic is now the third health facility in Kariba district to offer comprehensive cervical cancer services, after Kariba District Hospital and Siakobvu Hospital.
The clinic serves approximately 3 500 women and girls in wards 9 and 10, within a wider catchment population of about 7 000 people.
The introduction of the services was marked by the inaugural Mashonaland West Provincial Cervical Cancer Elimination Day commemorations held at Msampakaruma last Tuesday, where women accessed screening and treatment.
More significantly, the services will remain permanently available at the clinic, moving beyond periodic outreach programmes and ensuring continuity of care for women who require follow-up examinations or treatment.
The Government, through the Ministry of Health and Child Care, is working with its development partners to strengthen the facility’s capacity through the provision of equipment, training and technical support.
Technology intervenes
The package includes human papillomavirus (HPV) DNA testing through self-sampling, visual inspection with acetic acid and cervicography (VIAC), and treatment of precancerous lesions using thermal ablation, cryotherapy and the loop electrosurgical excision procedure (LEEP).
HPV is the main cause of cervical cancer, with persistent infection by high-risk strains potentially resulting in abnormal changes in cervical cells over time.
The availability of HPV testing allows health workers to identify women at risk before the disease advances, while the treatment procedures help remove or destroy abnormal tissue before it develops into invasive cancer.
Under the community-based screening programme, village health workers distribute HPV self-sampling kits and guide women on how to collect samples themselves.
The approach is expected to improve screening uptake by reducing barriers associated with distance, privacy and discomfort that some women experience with conventional screening procedures.
Healthcare providers follow up with women who test positive for further assessment and, where necessary, treatment.
The programme is also benefitting from the introduction of portable treatment technologies that make it possible to provide services in areas where electricity and specialised medical infrastructure are limited.
Unitaid has supported Zimbabwe’s adoption of portable, battery-powered thermal ablation and LEEP devices, which can operate even where electricity supplies are unreliable and can easily be transported to facilities beyond major hospitals. JNF has supported community-based HPV screening, procurement of portable LEEP equipment and the training of doctors at Kariba and Siakobvu hospitals.
Two healthcare providers from the hospitals underwent specialised LEEP training in July, strengthening the district’s capacity to manage women requiring more advanced treatment.
Provincial programme records significant gains
Speaking at the commemorations, Dr Blessing Munyawiri, who represented Mashonaland West provincial medical director Dr Kudzai Masendeke, said the region was making significant progress towards eliminating cervical cancer as a public health concern.
Since 2023, partnerships involving the Government, CHAI, JNF and Unitaid have helped vaccinate more than 55 000 girls against HPV and screen over 30 000 women across Mashonaland West.
In Kariba district, 20 trainers, 37 healthcare workers and 53 community health workers have received training to strengthen service delivery and community mobilisation.
More than 2 000 girls were vaccinated in 2025, while the number of facilities with dedicated visual inspection with acetic acid and camera (VIAC) screening rooms increased from one to three.
Siakobvu Hospital established its screening facility in March 2026, with Msampakaruma Clinic now joining the network.
Dr Munyawiri said cervical cancer remained the leading cancer affecting women in Zimbabwe, claiming approximately 2 300 lives annually.
Globally, the disease continues to claim hundreds of thousands of lives every year, despite being largely preventable through HPV vaccination, screening and timely treatment.
He called on parents and guardians to ensure that girls aged between nine and 14 receive the HPV vaccine, while women aged 25 to 49 should undergo regular cervical cancer screening.
Dr Munyawiri called on men, traditional leaders and churches to support women and girls in accessing preventive healthcare services.
Tackling barriers to early detection
Dr Munyawiri acknowledged that gaps remained, with some girls still unvaccinated and some women who test positive yet to access further care because of geographical barriers, misconceptions and fear.
The provincial health directorate is intensifying community engagement to address misinformation, encourage screening and strengthen follow-up mechanisms for women requiring further medical attention.
The commemorations also provided an opportunity for residents to access family planning and non-communicable disease screening services, reinforcing the importance of taking integrated healthcare to underserved communities.
Zimbabwe was among 194 countries that committed in 2020 to eliminating cervical cancer as a public health problem.
The global elimination strategy is anchored in three key interventions: vaccinating 90 percent of girls against HPV by the age of 15, screening 70 percent of women with a high-performance test by the ages of 35 and 45 and ensuring that 90 percent of women identified with cervical disease receive appropriate treatment.
The strategy recognises that eliminating cervical cancer requires more than raising awareness. It demands accessible vaccination, screening, diagnosis and treatment, supported by strong referral systems and sustained community participation.
For women in Msampakaruma, this ambition is now taking practical shape.
A journey that previously required travelling to distant hospitals can now begin and, in many cases, be completed at their local clinic, giving rural women a better chance to protect their health and lives.